This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Asana BioSciences, LLC
Drug Names(s): ASN 001, ASN-001
Description: ASN001 is a non-steroidal CYP17 inhibitor that suppresses testosterone synthesis. The compound selectively inhibits testosterone synthesis over cortisol synthesis, suggesting that it may not require co-administration of prednisone to mitigate mineralocorticoid excess.
Additional information available to subscribers only: